23 related articles for article (PubMed ID: 3663943)
1. In vitro purging of clonogenic leukaemic cells from human bone marrow by interferon-gamma-activated monocytes.
van de Loosdrecht AA; Ossenkoppele GJ; Beelen RH; Broekhoven MG; Schweitzer KM; Langenhuijsen MM
Cancer Immunol Immunother; 1994 May; 38(5):346-52. PubMed ID: 8162617
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and toxicity of plasma-cell-reactive monoclonal antibodies B-B2 and B-B4 and their immunotoxins.
Vooijs WC; Post J; Wijdenes J; Schuurman HJ; Bolognesi A; Polito L; Stirpe F; Bast EJ; de Gast GC
Cancer Immunol Immunother; 1996 Jul; 42(6):319-28. PubMed ID: 8830734
[TBL] [Abstract][Full Text] [Related]
3. Marvin Jules Stone, MD, MACP: a conversation with the editor. Interview by William Clifford Roberts.
Stone MJ
Proc (Bayl Univ Med Cent); 2001 Oct; 14(4):422-38. PubMed ID: 16369653
[No Abstract] [Full Text] [Related]
4. Selective depletion of human myeloma clonogenic stem cells from bone marrow cell preparations by a plasma-cell reactive antibody and complement.
Stone MJ; Tong AW; Fay JW; Lee JC
Cancer Detect Prev; 1988; 12(1-6):621-35. PubMed ID: 3180147
[TBL] [Abstract][Full Text] [Related]
5. Elimination of chemoresistant myeloma clonogenic cells from human bone marrow by monoclonal antibody and complement.
Tong AW; Dalton WS; Tsuruo T; Fay JW; Stone MJ
Prog Clin Biol Res; 1990; 333():155-64. PubMed ID: 2308979
[TBL] [Abstract][Full Text] [Related]
6. Elimination of chemoresistant multiple myeloma clonogenic colony-forming cells by combined treatment with a plasma cell-reactive monoclonal antibody and a P-glycoprotein-reactive monoclonal antibody.
Tong AW; Lee J; Wang RM; Dalton WS; Tsuruo T; Fay JW; Stone MJ
Cancer Res; 1989 Sep; 49(17):4829-34. PubMed ID: 2569359
[TBL] [Abstract][Full Text] [Related]
7. Elimination of drug-resistant myeloma tumor cell lines by monoclonal anti-P-glycoprotein antibody and rabbit complement.
Kulkarni SS; Wang ZM; Spitzer G; Taha M; Hamada H; Tsuruo T; Dicke KA
Blood; 1989 Nov; 74(6):2244-51. PubMed ID: 2572283
[TBL] [Abstract][Full Text] [Related]
8. Elimination of myeloma cells from bone marrow by using monoclonal antibodies and magnetic immunobeads.
Shimazaki C; Wisniewski D; Scheinberg DA; Atzpodien J; Strife A; Gulati S; Fried J; Wisniewolski R; Wang CY; Clarkson BD
Blood; 1988 Oct; 72(4):1248-54. PubMed ID: 3167207
[TBL] [Abstract][Full Text] [Related]
9. Elimination of clonogenic stem cells from human multiple myeloma cell lines by a plasma cell-reactive monoclonal antibody and complement.
Tong AW; Lee JC; Fay JW; Stone MJ
Blood; 1987 Nov; 70(5):1482-9. PubMed ID: 3663943
[TBL] [Abstract][Full Text] [Related]
10. Multiple myeloma cancer stem cells.
Huff CA; Matsui W
J Clin Oncol; 2008 Jun; 26(17):2895-900. PubMed ID: 18539970
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 in human multiple myeloma.
Klein B; Zhang XG; Lu ZY; Bataille R
Blood; 1995 Feb; 85(4):863-72. PubMed ID: 7849308
[No Abstract] [Full Text] [Related]
12. Tissue engineered models of healthy and malignant human bone marrow.
Chramiec A; Vunjak-Novakovic G
Adv Drug Deliv Rev; 2019 Feb; 140():78-92. PubMed ID: 31002835
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
